HSP60 is one of the breast cancer antigens that stimulate auto-antibody production, and in one study was detected in 31% cases of early stage breast cancer and in 32.6% cases of ductal carcinoma in situ (DCIS) compared to only 4.5% detection in healthy control patients [95]. This evidence concerns the gene HSPD1 and breast carcinoma.